Risk of Adverse Drug Events Following the Virtual Addition of COVID-19 Repurposed Drugs to Drug Regimens of Frail Older Adults with Polypharmacy

Lignende værker

• Risk of Adverse Drug Events Following the Virtual Addition of COVID-19 Repurposed Drugs to Drug Regimens of Frail Older Adults with Polypharmacy
  af: Sweilem B. Al Rihani, et al.
  Udgivet: (2020-08-01)
• Adverse drug event risk assessment by the virtual addition of COVID‐19 repurposed drugs to Medicare and commercially insured patients’ drug regimens: A drug safety simulation study
  af: Smith, Matt K., et al.
  Udgivet: (2021)
• Risk Assessment of Drug‐Induced Long QT Syndrome for Some COVID‐19 Repurposed Drugs
  af: Michaud, Veronique, et al.
  Udgivet: (2020)
• Disease-Induced Modulation of Drug Transporters at the Blood–Brain Barrier Level
  af: Al Rihani, Sweilem B., et al.
  Udgivet: (2021)
• Mechanisms of CYP450 Inhibition: Understanding Drug-Drug Interactions Due to Mechanism-Based Inhibition in Clinical Practice
  af: Deodhar, Malavika, et al.
  Udgivet: (2020)